Overexpression of PEP-19 Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
Abstract.: The precise molecular mechanisms leading to disturbance of Ca2+/calmodulin-dependent intracellular signalling in cardiac hypertrophy remains unclear. As an endogenous calmodulin regulator protein, the pathophysiology role of PEP-19 during cardiac hypertrophy was investigated in the presen...
Saved in:
Main Authors: | Yang-yang Xie (Author), Meng-meng Sun (Author), Xue-fang Lou (Author), Chen Zhang (Author), Feng Han (Author), Bo-ya Zhang (Author), Ping Wang (Author), Ying-mei Lu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
by: Yiping Li, et al.
Published: (2019) -
SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
by: Zhenzhen Li, et al.
Published: (2019) -
SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300
by: Peiye Shen, et al.
Published: (2016) -
Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes
by: Jung Seok Hwang, et al.
Published: (2021) -
Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
by: Masafumi Funamoto, et al.
Published: (2022)